Youngbo Chemical Co., Ltd.

KRX:014440.KS

3455 (KRW) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 90,279.0382,988.9399,741.753107,368.553131,196.068143,915.371164,618.163157,803.797157,352.294157,432.128163,838.811137,821.635130,734.86103,455.72683,465.31999,989.32995,393.955
Cost of Revenue 67,481.31862,727.60275,268.58583,269.18799,844.719111,846.698128,407.863118,278.767118,839.031125,978.893128,615.428108,436.124102,522.89978,319.12463,733.00979,943.64574,678.066
Gross Profit 22,797.71220,261.32824,473.16824,099.36631,351.34932,068.67336,210.339,525.0338,513.26331,453.23535,223.38329,385.51128,211.96225,136.60219,732.3120,045.68420,715.889
Gross Profit Ratio 0.2530.2440.2450.2240.2390.2230.220.250.2450.20.2150.2130.2160.2430.2360.20.217
Reseach & Development Expenses 1,975.4261,951.081,902.9511,344.032,102.752,387.3672,261.5262,138.881,794.8571,412.5471,477.7691,232.51,359.9681,131.6381,176.9261,160.5052,631.723
General & Administrative Expenses 1,664.528-1,653.3961,973.3622,069.2242,793.7362,812.793,288.2873,272.1646,131.3484,801.8524,046.4563,121.2392,513.5382,428.1261,622.0531,914.5151,960.118
Selling & Marketing Expenses 3,612.1814,805.4075,596.3516,496.0118,071.1869,162.1358,135.9227,639.7797,119.6317,147.2797,489.9796,711.9356,417.0126,213.1145,751.8146,356.3216,710.373
SG&A 15,847.1713,152.0117,569.7138,565.23510,864.92211,974.92511,424.20910,911.94313,250.97911,949.13111,536.4359,833.1748,930.558,641.247,373.8678,270.8368,670.491
Other Expenses 87.86310,184.759,081.2749,779.2379,936.353232.53825,913.657-71.564-518.121-1,608.03330.624-356.879,105.28-452.848-452.962-294.275-404.425
Operating Expenses 15,847.17115,287.84118,553.93819,688.50222,904.02524,835.44423,739.02623,216.0824,725.75423,275.76323,051.04620,968.79719,395.79816,754.57414,456.61716,763.69318,733.393
Operating Income 6,950.5414,973.4865,919.2294,410.8648,447.3247,233.22912,471.27316,308.9513,787.5088,177.47312,172.3378,416.7139,157.8048,382.035,275.6953,281.9941,982.497
Operating Income Ratio 0.0770.060.0590.0410.0640.050.0760.1030.0880.0520.0740.0610.070.0810.0630.0330.021
Total Other Income Expenses Net 43.8152,522.185-583.425-209.319338.836894.65925,478.864-233.327-703.648-2,734.198-1,122.946-2,050.945-876.579-503.4657,026.377-1,520.837-390.568
Income Before Tax 6,994.3557,495.6715,335.8044,201.5458,786.168,127.88837,950.13816,075.62213,083.865,443.27411,049.3916,365.7697,939.5857,878.56312,302.071,761.1541,591.928
Income Before Tax Ratio 0.0770.090.0530.0390.0670.0560.2310.1020.0830.0350.0670.0460.0610.0760.1470.0180.017
Income Tax Expense 915.546414.9941,834.091,542.6474,032.4352,470.4178,376.0994,855.2774,185.7912,086.0822,589.181,354.2551,735.2622,116.6332,799.723-44.6551,668.964
Net Income 5,960.7956,689.3293,501.7142,842.1375,120.4055,732.629,288.3510,908.5539,127.0023,687.588,430.095,021.7655,796.2975,761.9299,502.3471,524.5291,171.841
Net Income Ratio 0.0660.0810.0350.0260.0390.040.1780.0690.0580.0230.0510.0360.0440.0560.1140.0150.012
EPS 305.68343.04179.58145.75262.582941,5025594681894322582972954877860
EPS Diluted 305.68343.04179.58145.75262.582941,5025594681894322582972954877860
EBITDA 15,260.28913,197.94515,588.1414,491.68317,864.06715,550.61445,358.7623,947.16120,829.41913,679.48517,801.92212,847.75813,841.32412,230.57410,570.0936,692.8867,720.892
EBITDA Ratio 0.1690.1590.1560.1350.1360.1080.2760.1520.1320.0870.1090.0930.1060.1180.1270.0670.081